Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Southern Kuzbass reported for 2023 by IFRS

4/10/24 UKUZ

SberUnity launched syndicated transactions

4/10/24 SBER

Board of Directors of NLMK recommended dividends

4/10/24 NLMK

SberUnity launched syndicated transactions

4/10/24 OTCI

Korshunovsky GOK reported for 2023 by IFRS

4/10/24 KOGK

Shareholders of Positive Technologies Group approved dividends

4/10/24 POSI

Lukoil launches damaged unit at Volgograd Refinery

4/10/24 LKOH

Board of Directors of Chelyabinsk Press-Forging Plant recommended dividends

4/10/24 CHKZ

Novabev extended partnership with Ararat

4/10/24 BELU

O'Key sold plots of land for hypermarkets

4/10/24 OKEY